Annual Working Capital
$164.42 M
+$57.59 M+53.92%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual working capital is $164.42 million, with the most recent change of +$57.59 million (+53.92%) on December 31, 2023.
- During the last 3 years, TCRX annual working capital has risen by +$145.42 million (+765.40%).
- TCRX annual working capital is now at all-time high.
Performance
TCRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$245.43 M
-$15.53 M-5.95%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly working capital is $245.43 million, with the most recent change of -$15.53 million (-5.95%) on September 30, 2024.
- Over the past year, TCRX quarterly working capital has increased by +$61.01 million (+33.08%).
- TCRX quarterly working capital is now -5.95% below its all-time high of $260.96 million, reached on June 30, 2024.
Performance
TCRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TCRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.9% | +33.1% |
| 3 y3 years | +765.4% | +33.1% |
| 5 y5 years | +311.2% | +33.1% |
TCRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.9% | -6.0% | +182.6% |
| 5 y | 5-year | at high | +765.4% | -6.0% | +1191.8% |
| alltime | all time | at high | +765.4% | -6.0% | +1191.8% |
TScan Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $245.43 M(-6.0%) |
| Jun 2024 | - | $260.96 M(+95.9%) |
| Mar 2024 | - | $133.24 M(-19.0%) |
| Dec 2023 | $164.42 M(+53.9%) | $164.42 M(-10.8%) |
| Sep 2023 | - | $184.42 M(-11.0%) |
| Jun 2023 | - | $207.10 M(+138.4%) |
| Mar 2023 | - | $86.86 M(-18.7%) |
| Dec 2022 | $106.82 M | $106.82 M(-14.3%) |
| Sep 2022 | - | $124.58 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $112.19 M(-11.9%) |
| Mar 2022 | - | $127.28 M(-11.8%) |
| Dec 2021 | $144.31 M(+659.6%) | $144.31 M(-12.0%) |
| Sep 2021 | - | $164.06 M(+83.4%) |
| Jun 2021 | - | $89.45 M(-14.8%) |
| Mar 2021 | - | $105.03 M(+452.8%) |
| Dec 2020 | $19.00 M(-52.5%) | - |
| Dec 2020 | - | $19.00 M |
| Dec 2019 | $39.98 M | - |
FAQ
- What is TScan Therapeutics annual working capital?
- What is the all time high annual working capital for TScan Therapeutics?
- What is TScan Therapeutics annual working capital year-on-year change?
- What is TScan Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for TScan Therapeutics?
- What is TScan Therapeutics quarterly working capital year-on-year change?
What is TScan Therapeutics annual working capital?
The current annual working capital of TCRX is $164.42 M
What is the all time high annual working capital for TScan Therapeutics?
TScan Therapeutics all-time high annual working capital is $164.42 M
What is TScan Therapeutics annual working capital year-on-year change?
Over the past year, TCRX annual working capital has changed by +$57.59 M (+53.92%)
What is TScan Therapeutics quarterly working capital?
The current quarterly working capital of TCRX is $245.43 M
What is the all time high quarterly working capital for TScan Therapeutics?
TScan Therapeutics all-time high quarterly working capital is $260.96 M
What is TScan Therapeutics quarterly working capital year-on-year change?
Over the past year, TCRX quarterly working capital has changed by +$61.01 M (+33.08%)